| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | KX7K68Z2UH |
| Parent Compound: | ENZASTAURIN |
| InChI Key | UUADYKVKJIMIPA-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C32H30ClN5O2 |
| Molecular Weight | 552.08 |
| AlogP | 4.93 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 72.16 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 5.0 |
| Heavy Atoms | 39.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Glioblastoma | 3 | D005909 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Colonic Neoplasms | 2 | D003110 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Neuroblastoma | 1 | D009447 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107337 |
| EPA CompTox | DTXSID70189477 |
| FDA SRS | KX7K68Z2UH |
| PubChem | 176166 |
| SureChEMBL | SCHEMBL4325665 |